FDA Clears ASI’s GenASIs Advanced Imaging for UroVysion Analysis
GenASIs Scan & Analysis cleared for FISH Detection and Analysis of chromosomal abnormalities in urine specimens

2012/01/31

BioPharm Systems to Host Webinar on the Ins and Outs of CTMS Data Migration
Leading provider of Oracle's clinical trial, data, and drug safety software will discuss how the data in an exsiting clinical trial management system should be handled when migrating to a new application.

2012/01/20

Zhangjiagang Huamei to launch PDO products in April 2012
Zhangjiagang Huamei Biomaterial Co., Ltd. (Zhangjiagang Huamei) plans to launch its 1,3-propanediol (PDO) products in April 2012.

2012/01/11

SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis
SignaBlok, Inc., a Massachusetts-based emerging biopharmaceutical company, today announced that it has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s novel approach to the prevention and treatment of sepsis (blood poisoning), a serious medical condition characterized by a whole-body inflammatory state that often leads to death, and to establish proof of concept for this strategy in vivo.

2012/01/11

MEDomics to Present at OneMedForum San Francisco 2012
Advanced technologies in NextGen sequencing at MEDomics presents the opportunity to revolutionize the diagnosis of mitochondrial diseases, says Stan Yakatan, Chairman.

2012/01/05

SCIPRO Launches English Site for Feed Industry & Applications
On December 23, 2011, SCIPRO, a leading trace mineral element additive manufacturer, launches its English version website for global feed industry and applications.

2012/01/05

Licensing Announced for New Leukemia-Linked Mutations
TrovaGene Acquisition is Latest Addition to its Franchise of Proprietary Markers in Hematological Cancers

2012/01/05